Article
Leucoverdazyls as novel potent inhibitors of enterovirus replication
2024-04-11
Abstract excerpt
Enteroviruses (EV) are important pathogens causing human disease with various clinical manifestations. To date, treatment of enteroviral infections is mainly supportive since no vaccination or antiviral drugs are approved for their prevention or treatment. Here, we describe the antiviral properties and mechanisms of action of leucoverdazyls - novel heterocyclic compounds with antioxidant potential. The lead compou...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ef2742fc-d76c-5752-ab7d-7ce41c0316c9
- DOI
- 10.20944/preprints202404.0785.v1
